PUBLISHER: GlobalData | PRODUCT CODE: 1395943
PUBLISHER: GlobalData | PRODUCT CODE: 1395943
Urinary Tract Stents Market Size by Segments, Share, Regulatory, Reimbursement, Procedures and Forecast to 2033 is built to visualize quantitative market trends within Nephrology and Urology Devices therapeutic area.
The model discusses in detail the impact of COVID-19 on Urinary Tract Stents market for the year 2020 and beyond. Urinary tract stents are the tubular devices made either of polymers and metal which are inserted into the urinary tract or ureter to treat or prevent a blockage that prevents the flow of urine from the kidney to the bladder. A ureteral stent is specially designed a soft tube 10-12 inches in length that is placed in the ureter for draining urine from the kidney to the urinary bladder.
The increasing prevalence of prostate cancer, Benign Prostatic Hyperplasia (BPH), Urolithiasis and stone among people in the kidney has seen a staggering rise over the years. This is anticipated to propel the demand for urinary tract stenting over the forecast periods. The developing number of individuals facing difficulties in passing urine normally is one of the key reasons why the demand for urinary tract stenting is increasing throughout the years.
Each of the covered 39 country's color-coded and fully-sourced market models are equipped with epidemiology based indications with procedure volumes. To increase the data transparency, the interactive excel deliverable covers installed base, new sales volumes, product usage, average selling prices, market size and company share/rank analysis (wherever available). Moreover, analyst comments with qualitative insight offer context for quantitative data.
Key Inclusions of the market model are:
Currently marketed Urinary Tract Stents and evolving competitive landscape:
Global, Regional and Country level market specific insights:
Drive the understanding of the market by getting the veritable big picture including an overview of the healthcare system. In addition, the Market Access segment allows you to delve deeper into market dynamics with information on reimbursement policies and the regulatory landscape.
Robust methodologies and sources enable the model to provide extensive and accurate overview of the market. Demand and supply-side primary sources are integrated within the syndicated models, including Key Opinion Leaders. In addition, real world data sources are leveraged to determine market trends; these include government procedure databases, hospital purchasing databases, and proprietary online databases.
Companies covered: Boston Scientific Corp, Cook Group Inc, Becton Dickinson and Co, Olympus Corp, Coloplast A/S, Applied Medical Corporation, Allium Medical Solutions Ltd, Pnn Medical A/S, SRS Medical Systems Inc, and Others.
Countries covered: United States, United Kingdom, Germany, France, Italy, Spain, Brazil, China, India, Russia, Japan, Australia, Canada, Mexico, South Korea, Denmark, Ireland, Netherlands, New Zealand, South Africa, Sweden, Switzerland, Austria, Belgium, Finland, Israel, Norway, Poland, Portugal, Taiwan, Czech Republic, Greece, Hungary, Turkey, Egypt, Saudi Arabia, United Arab Emirates, Argentina and Chile.
This Market Model gives important, expert insight you won't find in any other source. The model illustrates qualitative and quantitative trends within the specified market. This model is required reading for:
The model will enable you to: